GENALICE’s analysis module improves diagnosis and treatment of patients with complex DNA diseases

On October 8th 2015, DTL’s partner GENALICE released a press release about a new standard for ultra-fast and highly reliable detection of all DNA changes in large patient cohorts. In a one-hour online event, the complete genomes of 800 Alzheimer Disease (AD) patients were processed, and by ingeniously using the aggregate information from the complete group, detection of DNA changes, or variants, in individual patients was enhanced.

The event, sponsored by Intel and Amazon Web Services (AWS), was organised to mark the launch of Population Calling, a new analysis module of the GENALICE MAP Next-Generation Sequencing (NGS) Data Analysis Suite. With this so-called Population Calling approach more known variants can be detected, the number of detection errors can be reduced, and more new variants can be discovered. This new solution has the potential to significantly accelerate precision medicine research and improve diagnosis and treatment of patients with complex DNA diseases.

This entry was posted in General.

Comments are closed.